Photo by nci from unsplash
e18524Background: ER testing in breast DCIS identifies patients who benefit from endocrine manipulation. We hypothesized that ER and PR testing on both biopsy and surgical tumor specimen may increa... Click to show full abstract
e18524Background: ER testing in breast DCIS identifies patients who benefit from endocrine manipulation. We hypothesized that ER and PR testing on both biopsy and surgical tumor specimen may increa...
Keywords:
retest rate;
progesterone receptor;
receptor progesterone;
receptor;
estrogen receptor;
receptor retest
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!